Beckman Coulter Life Sciences

BITC committee members selected Stephen Hessler and Tyler Daman for the award

Key laboratories worldwide contribute to collaboration.

Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (NYSE:DHR), announced today (July 16) that it has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics.

Acquisition will broaden product offering, provides Asian Operations Center.

Companies to Develop and Market Products Designed for Nanoparticle Characterization.

ASCB To Announce First Kaluza Prize Winner.

Beckman Coulter Life Sciences announces it is combining its Particle Characterization business with the Particle Counting business from Hach Company.

Beckman Coulter Life Sciences, an innovator in life science research, has acquired the flow cytometry business assets of ReaMetrix India Pvt. Ltd, a Bangalore-based life science technology company. The transaction provides Beckman Coulter Life Sciences with temperature-stable, single-dose, multi-color antibody cocktails targeting the HIV monitoring and clinical research markets.

As more therapeutic proteins enter the market, an even larger number accumulate in biopharmaceutical drug pipelines. In order to improve assay quality and manage the growing workload, automated systems are needed to provide qualitative and quantitative information.